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Abstract
Background: Health administrative data are increasingly used to examine disease occurrence.
However, health administrative data are typically available for a limited number of years – posing
challenges for estimating disease prevalence and incidence. The objective of this study is to estimate
the prevalence of people previously hospitalized with an acute myocardial infarction (AMI) using 17
years of hospital data and to create a registry of people with myocardial infarction.
Methods: Myocardial infarction prevalence in Ontario 2004 was estimated using four methods: 1)
observed hospital admissions from 1988 to 2004; 2) observed (1988 to 2004) and extrapolated
unobserved events (prior to 1988) using a "back tracing" method using Poisson models; 3) DisMod
incidence-prevalence-mortality model; 4) self-reported heart disease from the population-based
Canadian Community Health Survey (CCHS) in 2000/2001. Individual respondents of the CCHS
were individually linked to hospital discharge records to examine the agreement between self-
report and hospital AMI admission.
Results: 170,061 Ontario residents who were alive on March 31, 2004, and over age 20 years
survived an AMI hospital admission between 1988 to 2004 (cumulative incidence 1.8%). This
estimate increased to 2.03% (95% CI 2.01 to 2.05) after adding extrapolated cases that likely
occurred before 1988. The estimated prevalence appeared stable with 5 to 10 years of historic
hospital data. All 17 years of data were needed to create a reasonably complete registry (90% of
estimated prevalent cases). The estimated prevalence using both DisMod and self-reported "heart
attack" was higher (2.5% and 2.7% respectively). There was poor agreement between self-reported
"heart attack" and the likelihood of having an observed AMI admission (sensitivity = 63.5%, positive
predictive value = 54.3%).
Conclusion:  Estimating myocardial infarction prevalence using a limited number of years of
hospital data is feasible, and validity increases when unobserved events are added to observed
events. The "back tracing" method is simple, reliable, and produces a myocardial infarction registry
with high estimated "completeness" for jurisdictions with linked hospital data.
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Background
A cornerstone of population health is the estimation of
disease occurrence – both in terms of incidence (people
who newly develop a disease) and prevalence (the total
number of people living with a disease). Disease occur-
rence is routinely estimated using three methods. The two
most common are disease registries using active case iden-
tification (e.g. cancer registries) and health surveys that
ask people whether they have a disease. Health surveys are
either designed for specific diseases/conditions, or they
simultaneously gather information about several dis-
eases/conditions, along with other health status measures
and behaviours (e.g. smoking).
A third method, the focus of this study, uses routinely col-
lected health administrative data such as hospital dis-
charge data. Wider availability of health administrative
data has, in part, contributed to more widespread use of
these data for measuring disease occurrence. However,
health administrative data are often not available over
long time periods, which has made it difficult to distin-
guish people who newly develop a chronic disease from
those who have had the disease for a long time. Further-
more, health administrative data that are individually
linked across time and to different data sources have
increasingly been used to create registries of people with
chronic diseases. However, the registries do not include
people whose most recent event happened before the
availability of data.
This study seeks to demonstrate that hospital data can be
reliably used to estimate the number of people in Ontario,
Canada, who have ever been admitted to a hospital with
an acute myocardial infarction (AMI). We also demon-
strate that hospital data can be used to create a registry of
people with a myocardial infraction (MI). By examining
MI, we hope to better understand when health adminis-
trative data can be used to estimate disease prevalence and
to develop disease registries for other conditions.
Health administrative data are commonly used to meas-
ure disease occurrence. For the past five years in Canada,
the primary source of information on diabetes occurrence
has been the National Diabetes Surveillance System
(NDSS), using physician outpatient service and hospital
discharge data[1,2] Survival, migration and other demo-
graphic information are obtained by linking people with
diabetes to health care eligibility registries – which
include virtually all Canadians. Similar examples include
the Canadian Congenital Abnormality Surveillance Sys-
tem[3], the Canadian Stroke Network[4], and, within spe-
cific provinces, diseases/conditions such as injury[5],
congestive heart failure[6], and asthma[7]. Internation-
ally, there are more examples.
While commonly used to identify disease events, health
administrative data are rarely used to estimate disease
prevalence or to create registries, with the exception of sur-
veillance for two types of chronic diseases. The first type is
conditions such as diabetes that require frequent and con-
tinuous medical care, so that prevalent cases can be esti-
mated with just a few years of data. The second type is
conditions that are identified by acute manifestation of a
chronic disease and whose survival is low, such as conges-
tive heart failure,[8] where only a few years of observed
hospital events (acute exacerbation) and mortality data
are needed to reliably estimate the number of people cur-
rently living with the condition (prevalent cases).
AMI is unlike either of these two types of diseases. AMI is
an acute manifestation of coronary heart disease with
events usually separated by several years[9] Compared to
congestive heart failure, survival is more favorable (78%
one-year AMI survival in Ontario)[10].
The successful use of health administrative data to esti-
mate prevalence and create disease registries for diabetes
and congestive heart failure has encouraged us to examine
whether health administrative data can be used in more
challenging settings such as MI. Specific objectives of this
study are to: 1) estimate MI prevalence in 2004 using 17
years of hospital data (1988 to 2004); 2) create a registry
of people with an MI using the same data; 3) examine
how different periods of hospital discharge data (5, 10, 15
years) affect the reliability of prevalence estimates and the
registry's "completeness" (defined as the number people
in the registry compared to the estimated total number of
people previously hospitalized for AMI)[11]; and 4) com-
pare these prevalence estimates with other commonly
used methods, such as DisMod software and a population
health survey.
Methods
MI registry and prevalence populations
People were included into the MI registry if they had an
AMI hospitalization between 1988 and 2004 and, at the
time of the AMI event, were Ontario residents, age 20 to
105, and eligible for health care coverage (almost all resi-
dents).
To estimate MI prevalence in 2004 for the health admin-
istration method, we identified people in the MI registry
who were: alive for any time during 2004; eligible for
health care for any time during 2004; and used health care
at least once during 2002 or 2003 (to further exclude peo-
ple who were likely no longer Ontario residents). To com-
pute MI prevalence rates for 2004, adjusted population
estimates by Statistics Canada were used to calculate the
age-specific Ontario resident population. DisMod used
the identical MI registry and population estimates. Self-BMC Public Health 2007, 7:174 http://www.biomedcentral.com/1471-2458/7/174
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reported "heart attack" prevalence was estimated from the
Canadian Community Health Survey (CCHS), which
reflects community-dwelling Ontario residents in 2000/
01 (see below for details).
Data sources and AMI identification
Determining hospitalized AMI events using health administrative 
data
People with a hospital admission for AMI were identified
using the Discharge Abstract Database (DAD) of the
Canadian Institute for Health Information (CIHI). The
CIHI DAD contains demographic, administrative and
clinical information for all Ontario hospital admissions
since April 1, 1988.
AMI hospitalization was defined as any admission
between fiscal year 1988 to 2004 using International Clas-
sification of Diseases (ICD) codes 410 (9th revision) or
I21, I22 and I51.3 (10th revision). Coding accuracy of AMI
diagnosis using hospital discharge data has been validated
through multicentre chart audits (sensitivity 88.8%, spe-
cificity 92.8% for patients admitted to coronary care
units)[12-14] Admissions were excluded if the hospital
stay was less than four days for those discharged alive or if
the patient was transferred from another acute care facil-
ity. Complete details and rationale for the inclusion and
exclusion criteria have been reported previously[7].
People with an AMI admission were deterministically
linked using unique encrypted health card numbers to the
Ontario Registered Persons Database, which provided
data on mortality over time, regardless of where death
occurred, as well as periods of health care eligibility and
health care use (physician visit, drug prescription, hospi-
tal or emergency room visit).
Estimating self-reported "heart attack" from a population health 
survey
People with a self-reported "heart attack" were deter-
mined using the Canadian Community Health Survey 1.1
(CCHS 1.1), a national population-based health survey,
conducted by Statistics Canada between September 2000
and November 2001[15] Residents of Indian reserves,
long-term care institutions, prisons, and remote areas, as
well as Foreign Service personnel, were excluded. The
34,189 Ontario respondents over the age of 20 years were
asked for permission to link their responses to their health
administrative data (success rate 83.2%)[16] All respond-
ents were asked if they had heart disease diagnosed by a
physician and, if so, if they ever had a heart attack. The
respondents whose survey data were individually linked
to their CIHI DAD data were used to assess inter-database
reliability.
Data for DisMod
The DisMod software, offered by World Health Organiza-
tion, uses life-table or stationary population technique to
indirectly estimate the prevalence of a disease from the
most recent years of observed incidence and mortality
data[17] DisMod requires data on age-specific AMI inci-
dence rates, cause-specific mortality rates, and population
counts. CIHI DAD discharge records, as previous defined,
were used to estimate AMI incidence rates. All-cause and
MI specific mortality were from the Canadian Mortality
Database, Statistics Canada, for years 2001 to 2003.
Estimating prevalence
Prevalence using hospital discharge data
For Ontarians who were alive at the end of 2004 and had
a valid health card, we first counted the number of people
who had at least one hospital admission for MI from 1988
to 2004 ("observed events"). Then we added the esti-
mated number of people with an admission between
1920 and 1987 ("unobserved events" for the time period
with no available hospital data) in three steps. First, we
identified the most recent year of AMI hospitalization
from 2004 back to 1988. This is referred to as "back trac-
ing" events, which is the same as a time-to-event or sur-
vival analysis – except that the events are backward in
time, instead of the more typical approach of estimating
events looking forward in time[18]. These observed events
were grouped and plotted by year and sex for the age
groups 20–49, 50–64, 65–79, and 80 + years. The second
step assumed that the yearly observed event rates from
2004 to 1988 followed a Poisson distribution and used
maximum likelihood methods to predict the mean num-
bers of annual unobserved events from 1987 to 1920
using the model,
ln C(T - t) = α + β1 *(2004 - t) + β2 *(2004 - t)2, t = y ears
and T = 2004, where C(T-t) is the count of events.
The third step added the predicted annual unobserved
events for the years 1987 to 1920 (Cu), derived from the
model, to the observed events for the period 2004 to
1988, thereby estimating the overall prevalence rate for
the Ontario population, 2004.
In sensitivity analyses, we estimated the total prevalence
rate with fewer years of observed data and different predic-
tion formulas such as linear and exponential Poisson
models.
Prevalence using DisMod
Prevalence using DisMod was estimated by inputting into
the software by 5-year age groups: AMI incidence rates; all-
cause and AMI-specific mortality rates; and population
counts. The most current AMI incident rate was estimatedBMC Public Health 2007, 7:174 http://www.biomedcentral.com/1471-2458/7/174
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by identifying people with a hospital admission in 2004
and no AMI admission from 1988 to 2003.
Self-reported "heart attack."
The third method of estimating AMI prevalence used the
Ontario sample of the CCHS to obtain people with self-
reported "heart attack" by age groups.
Standard errors for unobserved hospital AMI admissions
were estimated from the predicted regression model.
Bootstrapping methods were used for self-reported "heart
attack." [19]
Results
The total number of adult Ontarians with at least one AMI
hospital admission during 1988–2004 was 346,915. Of
these people, 170,061 were alive in 2004 (1.8% of the
adult population). The remaining 170,740 people either
died (N = 170,740), emigrated (N = 2,143) or had no
recent contact with the health care system, likely because
they had emigrated or had an invalid health card (N =
3,971) (Figure 1). Table 1 shows the characteristics of
those with an AMI hospitalization. Mean period of fol-
low-up is less than 17 years (14.1 years), in part reflecting
immigration into Ontario from other countries. The cur-
rent yearly immigration rate exceeds 1% of the total pop-
ulation and about 30% of residents were born outside
Ontario.
Figures 2 and 3 shows both the number of observed AMI
hospitalizations between 1988 and 2004 and the extrapo-
lated (unobserved) AMI admissions from 1920 to 1988
based on Poisson model, by age and sex (Pseudo R2 = 1.00
for all curves). For the observed AMI hospitalizations,
there is a rapid decrease in the number of additional peo-
ple identified with an AMI admission, as one looks further
back in time.
The estimated prevalence of MI, combining both observed
and unobserved events, was 2.03% (95% confidence
interval [95%CI] 2.01 to 2.05%), or 188,000 people. The
"completeness" ratio is defined as the number of people
with observed AMI admission compared to the total
number of observed and unobserved admissions[11]
18,300 (95%CI 16,100 to 20,000) or 10% (95%CI 8.6%
to 10.5%) additional people are estimated to have had an
AMI prior to 1988, giving a completeness ratio of 0.90.
Most of the people with unobserved events were male and
older, reflecting higher AMI hospitalization rates for men
at younger ages (completeness ratio for men 0.89 versus
0.93 for women).
The estimated prevalence appears reliable and stable after
5 to 10 years of data (Figure 4). The estimated prevalence
changed very little if we used different Poisson models for
extrapolation (Pseudo R2 greater than 0.98 for all meth-
ods, not shown). Figure 5 plots the completeness ratio of
the registry with increasing number of years of hospital
data. With 5 years of hospital data, the completeness was
47%, slowly leveling off but continually increasing (90%
at 17 years of data).
Finally, we estimated the prevalence of MI using the Dis-
Mod approach and self-reported "heart attack" from a
population-based survey (Table 2). Both methods had
modestly higher prevalence estimates (2.5% and 2.7%,
respectfully); 1.2-fold higher (or 0.5% difference) for the
DisMod approach and 1.3 (or 0.7% difference) for the
self-reported estimate. Table 3 shows that there is poor
agreement between self-report of "heart attack" and the
likelihood of AMI hospitalization (sensitivity = 63.5%).
Discussion
In this study we used routinely collected hospital data to
estimate that 2.0% of people living in Ontario in 2004
have previously had an AMI hospital admission. We also
created a registry of 346,915 individual people with
known previous MI, of whom 170,061 people were alive
and living in Ontario in 2004.
This study demonstrates two strengths for the use of hos-
pital data to identify AMI events. First, the predicted prev-
alence estimates appear reliable, chiefly reflecting the
rapid and consistent decrease in the number of newly
identified events as the number of years of hospitalized
data increases. We used 17 years of hospital data, but prev-
alence estimates would be almost as reliable if fewer years
of hospital data were used (e.g. 5 to 10 years). Other stud-
ies assumed that only 5 years of data were needed to dis-
tinguish an AMI incidence case from a prevalent
case[20,21]. However, over half of Ontarians who were
hospitalized with an AMI with no AMI hospitalization in
the previous 5 years – what previous investigators would
label an "incident" case – had an earlier AMI hospitaliza-
tion, which means they are actually a prevalent case.
Second, 17 years of data can be used to create a reasonably
complete registry, one that contains 90% of people in
Ontario in 2004 who have ever been hospitalized for an
AMI. The appropriate level of completeness will probably
vary with specific applications and the degree to which
people in the registry reflect the total MI population. For
the 346,915 people in the MI registry, the registry contains
information as to the years in which they had an AMI hos-
pitalization, if and when they died, and if and when they
migrated to/from Ontario. People in the MI registry can
be individually linked to other disease registries (diabetes,
CHF, cancer, etc.), as well as to demographic, health status
and health care data (physician services, drug prescrip-
tions, home care, long-term care, other hospitalizations,BMC Public Health 2007, 7:174 http://www.biomedcentral.com/1471-2458/7/174
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Table 1: Characteristics of people living in Ontario, 2004 with a hospitalization for acute myocardial infarction, Ontario 1988 to 2004.
Men Women
Ontario Population 4,526,367 4,750,578
AMI Prevalence (%) 2.5 1.2
Mean Age 67.4 74.0
Age (%)
20–49 8.3 4.1
50–64 34.6 18.7
65–79 41.4 41.2
80+ 15.7 36.0
# of years with valid health insurace
0–5 0.5 0.4
6–10 1.7 1.3
11–15 6.1 4.3
15+ 91.8 93.9
# of years with AMI admissions (%)
18 8 . 4 8 9 . 3
21 0 . 0 9 . 1
3+ 1.7 1.7
Data Source: Statistics Canada, Hospital Discharge Abstract Database
Defining Myocardial Infarction to estimate its prevalence in Ontario, 2004 Figure 1
Defining Myocardial Infarction to estimate its prevalence in Ontario, 2004.
All patients with a hospitalization record 
for Acute Myocardial Infarction 
(ICD 9: 410 , ICD10: I21, I22, I51.3)
April 1, 1988 to March 31, 2005
Age 20 to 105 at time of admission
N=346,915
Discontinued Ontario Health Insurance 
Plan (OHIP).
N=2,143
Have not had contact with the health care 
system in the past two years. (Have a 
valid OHIP number )
N=3,971
AMI patients living in Ontario on
April 1, 2005
N=170,061
Have a registered date of death on or 
before March 31, 2005.
N = 170,740
Exclusion Criteria:BMC Public Health 2007, 7:174 http://www.biomedcentral.com/1471-2458/7/174
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Acute Myocardial Infarction events by most current hospitalization year, in Males alive in Ontario, 2004 Figure 2
Acute Myocardial Infarction events by most current hospitalization year, in Males alive in Ontario, 2004.
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Acute Myocardial Infarction events by most current hospitalization year, in Females alive in Ontario, 2004 Figure 3
Acute Myocardial Infarction events by most current hospitalization year, in Females alive in Ontario, 2004.
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Prevalence of AMI estimated using different number of observational years Caption: The number of years of hospital data start- ing with 2004 and adding additional years of historic hospital data, with 95% confidence interval Figure 4
Prevalence of AMI estimated using different number of observational years Caption: The number of years of hospital data start-
ing with 2004 and adding additional years of historic hospital data, with 95% confidence interval.
0.20
0.70
1.20
1.70
2.20
2.70
3.20
3.70
0 2 4 6 81 01 21 41 61 8
Number of Observation Years
P
r
e
v
a
l
e
n
c
e
 
P
e
r
c
e
n
t
 
o
f
 
M
I
,
 
2
0
0
4 17 years of data: 2.03%
Table 2: Comparing MI prevalence* in the adult population (age 20+), Ontario, Canada
Method Source of data Males Females Both Sexes
1. Observed Cumulative 
Prevalence from health 
services cohort
88-04 Hospital DAD & 88-
04 RPDB (Mortality)
2.53 1.17 1.83
2. Prevalence from simple 
mathematical model from 
AMI cohort data
88-04 Hospital DAD, 88-
04 RPDB (Mortality)
2.84 (2.76, 2.93) 1.26 (1.22, 1.31) 2.03 (2.01, 2.05)
3. Prevalence obtained 
using a life-table, disease 
simulation software 
(DisMod)
2004 Hospital DAD 
(Incidence), 2000 Vital 
Stats (Mortality), 2004 
Stats Can (Ontario 
Population Structure)
3.22 1.75 2.47
4. Prevalence estimate of 
self-reported population 
health survey (CCHS)†
CCHS 1.1, 2000–01, Public 
Use Microdata File
3.13 (2.95, 3.72) 2.05 (1.69, 2.34) 2.58 (2.41, 2.90)
*Age-Sex Standardized to the 2004 Ontario Population;
† The 95% percent confidence intervals were calculated using the bootstrap program for the linked CCHS 1.1 fileBMC Public Health 2007, 7:174 http://www.biomedcentral.com/1471-2458/7/174
Page 9 of 12
(page number not for citation purposes)
etc.). Amongst other uses, these linked data can be used to
examine health risk factors,[22] outcomes such as life and
health expectancy[23] and access, effectiveness, and
equity of health care and health policy[9,24-27]
Compared to MI prevalence estimated using observed
health administrative data plus unobserved extrapolated
cases, both DisMod and self-reported estimates of MI were
moderately higher. DisMod's uses the same observed
health administrative data, but models prevalence using
the assumption of a stationary population. This implies
that over time there has been no change in the incidence
of MI, life expectancy of the population, or the survival of
people with MI compared to those without MI. DisMod's
estimates for MI will thus be biased because all of these
factors have changed in Ontario. DisMod's method
remains helpful in many settings: it is easy to calculate
and does not require linked health care data. However,
DisMod should be used with caution when there are large
changes in disease incidence, survival or life expectancy.
Because self-reports often underestimate chronic disease
prevalence, we were surprised by the higher self-reported
"heart attack" estimates in our study [28-30]. People may
have difficulty differentiating a diagnosis of a "heart
attack" (AMI) from other types of heart disease.
Differences in the study populations among methods will
also contribute to differences in prevalence estimates. For
example, the CCHS sampled only community-dwelling
people. Self-reported MI prevalence estimates would be
higher if the CCHS also included the Ontario institutional
population, since this population has more chronic con-
ditions compared to people in the community. Disease
prevalence estimates are commonly reported for general
populations, when the data actually reflect differences
from the (implicit) general population. So, differing study
populations is a common problem when comparing dif-
ferent prevalence estimates. The MI registry closely reflects
the actual Ontario resident population.
Our method is the simplest available approach to esti-
mate MI prevalence when individually linked events, but
limited years of data, are available. Estimates are
improved by including extrapolated unobserved events.
We used Capocaccia and Angelis' concept of prevalence
"completeness," which is also similar to the approach by
Brameld et al. of "back tracing" data to estimate disease
incidence[11,18]. "Back tracing" is time-to-event or sur-
vival analyses, except the events are "backward" or historic
in time. The Ontario population is open, meaning that
there are births, deaths, immigration and migration. The
Completeness of the MI Registry, 1 to 17 years of observational years Caption: The completeness of the MI registry Figure 5
Completeness of the MI Registry, 1 to 17 years of observational years Caption: The completeness of the MI registry.
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usual "forward" time-to-event approach, excludes people
from prevalence estimates if they die or emigrate. In the
"backward" approach, people are excluded at birth (event
at age 20 years in this study) or prior to immigration into
Ontario. By definition, deaths and emigration are not a
concern in the backward time-to-event analyses. AMI
events are only ascertained for people who were alive and
living in Ontario in 2004.
In the present study, "completeness" was used both to
estimate prevalence and to characterize the MI registry.
Capocaccia and Angelis sought to estimate prevalence
completeness for different time periods of observation
when survival and incidence rates are known. Our
method has the advantage of not specifically requiring
information on survival, disease incidence, or other fac-
tors like migration and repeated events; the latter may be
important when estimating completeness for high-migra-
tion populations like Ontario and conditions like MI.
Brameld et al. estimated disease incidence using the pro-
portion of newly identified cases that are truly new (inci-
dent) cases. Our measure of completeness can be similarly
used to easily and reliably estimate MI incidence. With a
completeness of 90% in 2004, a newly observed AMI hos-
pitalization in 2005 has about a 90% likelihood of being
a first admission (in other words, an incident case).
Most of the limitations in estimating MI prevalence by
means of hospital data are neither unique to this method
nor easily addressable. There are three main limitations
that reflect: 1) the relatively narrow scope of disease iden-
tified using hospitalized AMI; 2) changes to AMI diagno-
sis and classification; and, 3) reliance on extrapolating
unobserved events.
First, not all people who have an AMI are admitted to hos-
pital. Some people with symptoms do not go to hospital,
while others with a "silent AMI" may not have symptoms.
Of further note, hospitalization data does not identify the
1/3 of people with an incident AMI who die before reach-
ing hospital (of course these people do not become prev-
alent cases)[31] The DisMod method of prevalence
estimation has the same limitations when hospital dis-
charge data are used. Additional AMI events (not hospital-
ized) can be identified by using diagnostic tests such as
electrocardiograms (ECGs). Thus, self-reported "heart
attack" may include some people who were not hospital-
ized, but had these tests. However, our linkage between
hospital data and self-reports indicates that 36% (0.78/
2.12) of people who had an AMI did not report having a
"heart attack," raising concerns about the reliability of
self-reporting MI. The use of a population-based survey
with an examination that includes an ECG is probably the
most robust way of estimating MI prevalence. However,
this method is costly and will also miss the rising propor-
tion of MIs that do not have ECG changes[32] For stroke
incidence, Feigin has advocated the use of multiple data
sources both to ensure the identification of non-hospital-
ized stroke and to validate case ascertainment from any
one source of data[33] A similar approach for MI would
be appropriate.
Second, the diagnosis and classification of MI and coro-
nary heart disease has changed, and this affects most prev-
alence estimation methods. The use of more sensitive
diagnostic tests such as blood troponin-I levels has
increased the number of "mild" AMI events and events
that do not have lasting ECG findings, typically classified
by clinicians as "non-ST elevation MI" or "non-Q-wave
MI"[32] Furthermore, changes from ICD9 to ICD10
(2002 in Ontario) may further affect MI estimates. Our
prevalence estimate reflects AMI diagnosis and classifica-
tion at the time of a person's most recent AMI event.
The third limitation of our method is the reliance on
extrapolating events prior to available hospital data. The
clear and consistent pattern of diminishing AMI events
over time was reassuring. Additional (or fewer) years of
data would have a small effect on our prevalence esti-
mates. However, we did not specifically examine the
degree to which changes in demography and disease proc-
ess influence our prevalence estimates, for both observed
Table 3: Comparing Prevalence of Hospitalized Myocardial Infarction in Ontario, 1988 to 2001, data vs. self-reported 'Heart Attack' in 
the 2000/01 Canadian Community Health Survey
Hospital record for Acute Myocardial Infarction ?
Yes No
Self reported heart attack in CCHS Yes N (sample) 116,361 (536) 97,899 (431)
weighted % 1.35 1.13
No N (sample) 66,945 (278) 8,355,870 (27,217)
weighted % 0.78 96.74
Total hospitalized with Acute Myocardial Infarction: 2.12%;
Total self-reported heart attack: 2.49%;
Sensitivity: 63.5%; Specificity: 98.6%; Positive Predictive Value: 54.3%BMC Public Health 2007, 7:174 http://www.biomedcentral.com/1471-2458/7/174
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and extrapolated cases. More complex population models
start with a historic population and simulate how many
cases will develop over time, given changing disease and
demographic factors[34,35] The extra work required to
create such models would likely not improve prevalence
estimates compared to our approach, in part because
complex disease models also have assumptions due to
missing historic disease and demographic information
(incidence, population structure, overall and disease-spe-
cific survival). An advantage to our approach is the sim-
plicity and apparent reliability for conditions such as MI
(characterized by occasional repeated events and moder-
ate survival) and for populations such as Ontario (with
moderate migration). The DisMod model is another sim-
ple way to estimate disease prevalence and appears rea-
sonably reliable. Most disease models, whether they are
simple or complex, do not uniquely identify people in a
registry, and so are not as useful for many evaluative pur-
poses.
Conclusion
Health administrative data, such as hospital admission
data, are increasingly used to estimate the occurrence of
disease events. They have also been used to estimate the
incidence and prevalence of disease for conditions that
have either frequent repeated events or health care
encounters (such as people with diabetes) and/or have a
poor survival (such as congestive heart failure).
We showed that for MI – which has neither frequent
events nor poor survival – a simple method that uses hos-
pitalization data for a modest number of years can reliably
estimate MI prevalence. We currently have a registry of
90% of the people in Ontario with a previous AMI hospi-
talization. This registry can be individually combined
with other health care data (such as prescribed medica-
tions, physician services, etc.) to evaluate health care for
people with an MI, amongst other descriptive and evalua-
tive studies.
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